Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Deafness

3,4-dihydroxyphenylacetic acid has been researched along with Deafness in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Deafness: A general term for the complete loss of the ability to hear from both ears.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunt, DL1
Yamoah, EN1
Krubitzer, L1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Deafness

ArticleYear
Multisensory plasticity in congenitally deaf mice: how are cortical areas functionally specified?
    Neuroscience, 2006, Volume: 139, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Animals; Brain Mapping; Calcium-Transporting A

2006